Decreased blood levels of VEGF-A have also been described after clinical presentation of ASD, both in humans where VEGF-A levels were significantly lower in autism cases compared to Retts syndrome71, and in VPA-induced autism mouse models72. This evidence concerns the gene VEGFA and autism.